Evidence map›Paper›PMID 34575146›Full record

ArticleJournal of clinical medicine2021

Prevalence of Chronic Heart Failure, Associated Factors, and Therapeutic Management in Primary Care Patients in Spain, IBERICAN Study.

Jose L Llisterri-Caro, Sergio Cinza-Sanjurjo, Vicente Martín-Sánchez, Gustavo C Rodríguez-Roca, Rafael M Micó-Pérez, Antonio Segura-Fragoso, Sonsoles Velilla-Zancada, Jose Polo-García, Alfonso Barquilla-García, Luis Rodríguez Padial and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Jose L Llisterri-CaroSpanish Society of Primary Care Physicians (SEMERGEN)'s Foundation, 28009 Madrid, Spain.
Sergio Cinza-SanjurjoPorto do Son Health Center, Health Area of Santiago de Compostela, 15970 Santiago de Compostela, Spain.ORCID 0000-0002-4486-2820
Vicente Martín-SánchezInstitute of Biomedicine (IBIOMED), University of León, 24004 León, Spain.ORCID 0000-0003-0552-2804
Gustavo C Rodríguez-RocaLa Puebla de Montalbán Health Table Center, 45516 Toledo, Spain.
Rafael M Micó-PérezFontanars dels Alforins Health Center, Xàtiva-Ontinyent Department of Health, 46635 Valencia, Spain.
Antonio Segura-FragosoMedicine Department, University of Castilla-La Mancha, 13003 Toledo, Spain.ORCID 0000-0003-4884-2242
Sonsoles Velilla-ZancadaJoaquin Elizalde Health Center, 26004 Logroño, Spain.
Jose Polo-GarcíaCasar de Cáceres Health Center, 10190 Cáceres, Spain.
Alfonso Barquilla-GarcíaTrujillo Health Center, 10200 Cáceres, Spain.
Luis Rodríguez PadialServicio de Cardiología, Complejo Hospitalario de Toledo, 45071 Toledo, Spain.
Miguel A Prieto-DíazVallobín-La Florida Health Center, 33012 Oviedo, Spain.
On Behalf Of The Investigators Of The Iberican Study And Of The Spanish Society Of Primary Care Physicians Semergen 's Foundation
Complejo Hospitalario de Cáceres · ESCentre for Biomedical Network Research on Rare Diseases · ESComplejo Hospitalario Universitario de Toledo · ESSpanish Society of Family and Community Medicine · ESUniversity of Castilla-La Mancha · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of chronic heart failure (CHF) in patients assisted in primary care is not well known. We investigated the prevalence of CHF, its associated factors, and its therapeutic management. METHODS AND

findingsThis was a cross-sectional, multicenter study conducted in primary care (PC) in baseline patients of the IBERICAN study (Identification of the Spanish Population at Cardiovascular and Renal Risk). CHF was defined as the presence of this condition in the medical history, classifying patients according to the type of ventricular dysfunction in CHF with preserved ejection fraction (pEF), or CHF with reduced ejection fraction (rEF). Clinical characteristics, relationship between CHF and main cardiovascular risk factors (CVRF), and drug treatments used according to ejection fraction (EF) were analyzed.

resultsA total of 8066 patients were included (54.5% women), average age (SD) was 57.9 (14.8) years, of which 3.1% (95% CI: 2.3-3.7) presented CHF, without differences between men and women. CHF with pEF (61.8%; 95% CI: 55.5-67.6) was more frequent in women, and CHF with rEF (38.1%; 95% CI: 33.2-45.5) (

conclusionsThree in every 100 patients included in the IBERICAN study presented CHF, of which two thirds had pEF. The condition increased exponentially with age and aggregation of CVRF. We did not find any differences in drug treatment according to the type of ventricular dysfunction. The treatment of HF with rEF has much room for improvement.

Indexed as

chronic heart failuredrug treatmentprevalenceprimary care

Identifiers

PMID34575146
PMCPMC8471153
OpenAlexW3196399910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.